News | February 06, 2008

UK Hospital Debuts Use of Image-Guided Intensity Modulated Arc Therapy

February 7, 2008 - The first image-guided intensity modulated arc therapy patient treatment using commercially released product solutions was completed using Elekta Synergy image guided system fitted with the new Elekta linear accelerator control system.

The Royal Marsden Hospital in Sutton UK used an Elekta Synergy image guided system fitted with the new Elekta linear accelerator control system in order to deliver volumetric intensity modulated arc therapy (VMAT) to a patient undergoing a course of radiation therapy treatment for lung cancer.

Allgemeines KrankenHaus/Medical University of Vienna (AKH) in Austria delivered the world’s first PreciseBEAM VMAT treatment. PreciseBEAM VMAT is delivered as a combination of optimized treatment planning using Ergo and an Elekta Synergy linear accelerator, upgraded with a next generation digital control system.

The treatment was to an intracranial glioblastoma and consisted of 3 noncoplanar VMAT arcs with variable gantry speed and simultaneous leaf movement and rotation of the dynamic multileaf collimator. The patient had a brain lesion very close to vital structures such as hypophisys, brain stem, optical nerves, and lenses of the eyes, however the treatment was completed within 10 minutes – including set-up, Imaging, repositioning and delivery.

VMAT capability is CE marked as part of the new linear accelerator control system and may require additional regulatory clearances for sale in other regions of the world.

For more information: www.elekta.com

Related Content

Accuray Launches Synchrony Motion Tracking and Correction Technology for Radixact System
Technology | Image Guided Radiation Therapy (IGRT) | April 24, 2019
Accuray announced the launch of its Synchrony motion tracking and correction technology to be used with the Radixact...
FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S.
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
Hypofractionated Radiation Provides Same Prostate Cancer Outcomes as Conventional Radiation
News | Intensity Modulated Radiation Therapy (IMRT) | October 31, 2018
An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with...
Elekta Introduces Strategy for Precision Radiation Medicine at ASTRO 2018

Elekta SmartClinic is one of the key features in the Mosaiq Plaza suite of data-focused integrative oncology software

News | Radiation Therapy | October 30, 2018
At the American Society for Radiation Oncology (ASTRO) Annual Meeting, Oct. 21-24 in San Antonio, Elekta introduced the...
ViewRay and Miami Cancer Institute Host Symposium on MR-Guided Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | October 05, 2018
October 5, 2018 — Leading oncology experts from around the world recently met to discuss the integration of...
Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...